Laporan Laba Rugi (TTM)
Laporan Laba Rugi Regen BioPharma, Inc. - Preferred Stock menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 0.00 | 0.00 | 26.55 | 22.98 | 18.48 | 15.26 | 0.89 | -0.15 | 0.00 | 0.30 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 0.00 | 0.00 | 26.55 | 22.98 | 18.48 | 15.26 | 0.89 | -0.15 | 0.00 | 0.30 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Change (%) | -35.90 | -12.26 | 23.89 | 57.23 | 1.50 | 9.00 | 0.46 | -19.55 | 125.99 | 4.57 | 1.79 | -1.35 | -41.21 | 4.43 | 8.09 | 6.17 | -2.77 | 10.76 | -6.43 | |
| % of Revenue | 278.21 | 178.33 | 156.47 | 153.18 | 195.84 | 167.76 | 158.65 | 157.97 | 127.27 | 287.60 | 299.87 | 304.77 | 300.65 | 176.75 | 184.59 | 199.51 | 211.81 | 205.95 | 228.10 | 213.43 |
| R&D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -48.11 | -33.52 | 310.76 | 94.97 | 312.13 | 42.21 | 7.81 | 18.74 | -7.33 | -10.94 | 6.13 | -11.99 | -22.60 | 2.24 | -7.44 | -1.17 | -30.93 | -37.81 | -49.22 | |
| % of Revenue | 12.08 | 6.27 | 4.17 | 13.52 | 21.44 | 74.58 | 92.02 | 98.33 | 116.93 | 108.36 | 96.22 | 101.97 | 89.74 | 69.46 | 71.02 | 65.73 | 64.97 | 44.88 | 27.91 | 14.17 |
| OpEx | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -36.41 | -12.98 | 31.33 | 60.29 | 32.15 | 19.22 | 3.16 | -4.86 | 62.15 | 0.33 | 2.84 | -4.02 | -36.93 | 3.82 | 3.77 | 4.35 | -9.38 | 2.07 | -11.10 | |
| % of Revenue | 290.29 | 184.60 | 160.64 | 166.70 | 217.28 | 242.34 | 250.67 | 256.30 | 244.20 | 395.97 | 396.09 | 406.75 | 390.39 | 246.21 | 255.60 | 265.25 | 276.78 | 250.82 | 256.01 | 227.60 |
| Operating Income | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -55.54 | -28.33 | 39.21 | 116.22 | 43.80 | 22.00 | 4.66 | -7.88 | 105.25 | 0.34 | 3.75 | -5.33 | -49.65 | 6.43 | 6.20 | 6.98 | -14.68 | 3.44 | -18.21 | |
| % of Revenue | -190.29 | -84.60 | -60.64 | -66.70 | -117.28 | -142.34 | -150.67 | -156.30 | -144.20 | -295.97 | -296.09 | -306.75 | -290.39 | -146.21 | -155.60 | -165.25 | -176.78 | -150.82 | -156.01 | -127.60 |
| Interest Expense | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -18.99 | -25.57 | -27.96 | -10.39 | -14.30 | -3.38 | -2.43 | -29.25 | -19.12 | -30.91 | -32.87 | -24.46 | 8.06 | 14.47 | 10.65 | 24.67 | 15.61 | 11.58 | 11.76 | |
| % of Revenue | -857.21 | -694.44 | -516.88 | -294.24 | -214.39 | -155.08 | -130.00 | -125.72 | -89.08 | -72.05 | -49.63 | -33.27 | -25.13 | -27.16 | -31.09 | -34.40 | -42.88 | -49.58 | -55.32 | -61.82 |
| Net Income | 3 | 2 | 7 | -4 | -7 | -6 | -73 | 1 | 2 | 1 | 68 | 1 | 1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Change (%) | -41.48 | 226.19 | -164.10 | 61.94 | -14.47 | 1,166.89 | -101.55 | 114.93 | -41.30 | 4,673.19 | -97.95 | -17.60 | -153.97 | 10.81 | 4.47 | 20.03 | 42.72 | -8.33 | 3.28 | |
| % of Revenue | 3,104.02 | 1,816.37 | 5,924.86 | -3,001.10 | -3,951.79 | -2,852.88 | -31,358.84 | 482.01 | 1,037.52 | 608.99 | 28,982.82 | 593.30 | 488.89 | -263.85 | -292.37 | -305.43 | -366.61 | -523.21 | -479.62 | -495.34 |
Source: Capital IQ
